| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | President and CEO
1 company
Marshall Fordyce is President and CEO at VERA. From August 2022 to September 2026, the filings on record show 0 open-market purchases and 27 sales. Marshall Fordyce's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $7.2M at current prices.
Historically, Marshall Fordyce's trades have earned a strong insider score of 74/100 across 30 rated trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +10.9%.
The VERA filings lean toward selling, a net 581,690 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2023 | VERA Vera Therapeutics, Inc. | President and CEO | Sell10b5-1 | 5,210 | $16.66 | $86,778.80 | -2.1% | -25.0% | +123.3% | |
| Oct 4, 2022 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE | 32,000 | $20.90 | $668,773.28 | -15.0% | -17.5% | -41.6% | |
| Sep 13, 2022 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE | 22,363 | $21.16 | $473,236.21 | -11.0% | -14.5% | -19.4% | |
| Sep 12, 2022 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE | 29,022 | $20.43 | $592,812.45 | -13.8% | -15.3% | -14.9% | |
| Sep 8, 2022 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE | 21,891 | $20.37 | $445,878.67 | -10.8% | -20.9% | -10.3% | |
| Sep 2, 2022 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE | 34,196 | $21.09 | $721,236.26 | -15.9% | -14.9% | -3.5% | |
| Aug 12, 2022 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE | 20,528 | $20.16 | $413,799.32 | -13.0% | -20.0% | -9.2% |